RET inhibitors for patients with RET fusion-positive and RET wild-type non-small-cell lung cancer.
Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain; Autonomous University of Barcelona, Barcelona, Spain; Germans Trias i Pujol Health Sciences Research Institute, Badalona, Spain. Electronic address: rrosell@iconcologia.net.
Rafael
R
Rosell
Germans Trias i Pujol Health Sciences Research Institute, Badalona, Spain; University Hospital Sagrat Cor, Barcelona, Spain.
Niki
N
Karachaliou
D000230:Adenocarcinoma; D002289:Carcinoma, Non-Small-Cell Lung; D006801:Humans; D008175:Lung Neoplasms; D015514:Oncogene Proteins, Fusion; D051096:Proto-Oncogene Proteins c-ret
D015514:Oncogene Proteins, Fusion; D051096:Proto-Oncogene Proteins c-ret